Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
370,511,797
-
Share change
-
+10,035,823
-
Total reported value
-
$1,192,936,483
-
Put/Call ratio
-
26%
-
Price per share
-
$3.22
-
Number of holders
-
74
-
Value change
-
+$30,768,198
-
Number of buys
-
39
-
Number of sells
-
24
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q3 2022
As of 30 Sep 2022,
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
370,511,797 shares.
The largest 10 holders included
QVT Financial LP, SB INVESTMENT ADVISERS (UK) LTD, VIKING GLOBAL INVESTORS LP, Two Seas Capital LP, BlackRock Inc., SC CHINA HOLDING Ltd, Anchorage Capital Group, L.L.C., FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and Woodline Partners LP.
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.